Proprietary R&D

Focus on R&D of First-in-Class and Best-in-Class innovative drugs that are globally competitive, not generics or me-too drugs. This strategy allows the company to achieve higher commercial returns and premium pricing.

Integration of Resources

Use “Sanya + Shanghai” two centers layout. Sanya, as center of global operations and strategy, is entitled to incentives offered by Hainan policies, whereas Shanghai office effectively leverages shanghai as a hub of talent, capital and clinical resources in China’s biomedical industry.

Policy Advantages

Make full use of Hainan Free Trade Port's unique advantages in tax incentives (such as corporate income tax reductions), talent recruitment, tariff exemptions, cross-border capital flows, and pilot policies, greatly reducing operating costs and accelerating research, development, and internation...

International Capital Operations

The company possesses international perspective, standards, and network, giving it significant advantages in financing, cross-border cooperation, technology in-licensing, and future global market development, enabling it to create sustainable value for shareholders.